Russell Thirsk - Bavarian Nordic Ex COO

BVNRY Stock  USD 9.10  0.11  1.22%   

Insider

Russell Thirsk is Ex COO of Bavarian Nordic AS
Phone45 33 26 83 83
Webhttps://www.bavarian-nordic.com

Bavarian Nordic Management Efficiency

The company has return on total asset (ROA) of (0.0197) % which means that it has lost $0.0197 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0942) %, meaning that it generated substantial loss on money invested by shareholders. Bavarian Nordic's management efficiency ratios could be used to measure how well Bavarian Nordic manages its routine affairs as well as how well it operates its assets and liabilities.
Bavarian Nordic AS has accumulated 179.41 M in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Bavarian Nordic AS has a current ratio of 1.94, which is within standard range for the sector. Debt can assist Bavarian Nordic until it has trouble settling it off, either with new capital or with free cash flow. So, Bavarian Nordic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bavarian Nordic AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bavarian to invest in growth at high rates of return. When we think about Bavarian Nordic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christian MuellerImmutep Ltd ADR
N/A
Brian SullivanElevation Oncology
N/A
Daniel CalkinsVerastem
36
David DornanElevation Oncology
46
Wolfgang MDRigel Pharmaceuticals
58
Erin CoxVerastem
N/A
Stephen JDGeron
74
Michelle MDVerastem
48
Mba MBAVerastem
70
Ryan BloomerElevation Oncology
N/A
Jonathan PachterVerastem
66
Robert WeinbergVerastem
N/A
Shengfei FangImmutep Ltd ADR
N/A
Valerie MDElevation Oncology
46
BPHARM RPhVerastem
63
Piyush GuptaVerastem
N/A
Sean FlynnVerastem
50
Joseph FerraElevation Oncology
49
RPh PharmDElevation Oncology
40
Bavarian Nordic AS develops, manufactures, and commercializes life-saving vaccines. Bavarian Nordic AS was incorporated in 1992 and is headquartered in Hellerup, Denmark. Bavarian Nordic is traded on OTC Exchange in the United States. Bavarian Nordic AS [BVNRY] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Bavarian Nordic AS Leadership Team

Elected by the shareholders, the Bavarian Nordic's board of directors comprises two types of representatives: Bavarian Nordic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bavarian. The board's role is to monitor Bavarian Nordic's management team and ensure that shareholders' interests are well served. Bavarian Nordic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bavarian Nordic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anu Kerns, Ex Officer
Russell Thirsk, Ex COO
Laurence Moerlooze, Ex Officer
Paul MSc, CEO Pres
JeanChristophe May, Ex Officer
Rolf Srensen, VP Communications
Henrik MSc, CFO VP

Bavarian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bavarian Nordic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bavarian Pink Sheet Analysis

When running Bavarian Nordic's price analysis, check to measure Bavarian Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bavarian Nordic is operating at the current time. Most of Bavarian Nordic's value examination focuses on studying past and present price action to predict the probability of Bavarian Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bavarian Nordic's price. Additionally, you may evaluate how the addition of Bavarian Nordic to your portfolios can decrease your overall portfolio volatility.